The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Åke Borg

Åke Borg

Principal investigator

Åke Borg

Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Author

  • Pavel Elsakov
  • Lenka Foretova
  • Petr Goetz
  • Johannes W. B. de Groot
  • Winette T. A. van der Graaf
  • Gulnur Guler
  • Kay Huebner
  • Neva E. Haites
  • Ute Hamann
  • Judy Ho
  • Evgeny N. Imyanitov
  • Arvids Irmejs
  • Gunta Purkalne
  • Marianna Bitina
  • Andris Gardovskis
  • Janis Gardovskis
  • Youlia M. Kirova
  • Alain Fourquet
  • Jean-Yves Pierga
  • Dominique Stoppa-Lyonnet
  • Lidia Larizza
  • Cornelis J. M. Lips
  • Niklas Loman
  • Åke Borg
  • Pal Moller
  • Håkan Olsson
  • Jae-Gahb Park
  • Sinisa Radulovic
  • Mira Brankovic-Magic
  • Thangarajan Rajkumar
  • Evangelia Razis
  • Drakoulis Yannoukakos
  • Fernando Schmitt
  • Rita Schmutzler
  • Peter D. Simmonds
  • Diana Eccles
  • Jacob Smeltzer
  • Peter T. Silberstein
  • Henry Lynch
  • Walter Weber
  • Pax H. B. Willemse
  • Rolf H. Sijmons
  • Piotr J. Wysocki
  • Vladimir Zajac
  • Zheng Shu
Show all

Department/s

  • Breastcancer-genetics

Publishing year

2007

Language

English

Pages

119-143

Publication/Series

Hereditary Cancer in Clinical Practice

Volume

5

Issue

3

Document type

Journal article (comment)

Publisher

Termedia Publishing House Ltd.

Topic

  • Cancer and Oncology

Status

Published

ISBN/ISSN/Other

  • ISSN: 1897-4287